Indication

Idiopathic neutropenia

Idiopathic neutropenia is an acquired hematologic disorder of the immune and hematopoietic systems characterized by a persistent reduction in the absolute neutrophil count below normal thresholds without an identifiable secondary cause. Read more about Idiopathic neutropenia

8 drugs 5 manufacturers

Advertisement

Drugs that treat it

Common Idiopathic neutropenia therapies.

Showing 1–8 of 8 drugs

Filter & compare in the drug finder →Opens the drug finder with Idiopathic neutropenia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Idiopathic neutropenia.

Idiopathic neutropenia is an acquired hematologic disorder of the immune and hematopoietic systems characterized by a persistent reduction in the absolute neutrophil count below normal thresholds without an identifiable secondary cause.

Diagnosed by exclusion, it occurs across pediatric and adult populations following the rule-out of congenital syndromes, nutritional deficiencies, hematologic malignancies, medications, active infections, and defined systemic autoimmune diseases.

Pathophysiologically, the condition is frequently driven by dysregulated immune mechanisms, including cytokine- or T-cell-mediated suppression of granulopoiesis in the bone marrow or occult autoantibody-mediated peripheral destruction of granulocytic lineages.

Clinically, affected individuals may remain asymptomatic or present with recurrent mucocutaneous infections, aphthous stomatitis, periodontal inflammation, and fatigue, typically maintaining a benign overall prognosis.

Personalize your experience

Follow Idiopathic neutropenia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it